Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation
- PMID: 16038717
- DOI: 10.1016/j.thromres.2005.01.005
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation
Abstract
To test the hypothesis that the new CHADS2 and Framingham point-based risk stratification scores could be related to plasma vWf (a plasma index of endothelial damage/dysfunction) and soluble E-selectin (an index of endothelial activation) levels in a large cohort of AF patients, we studied 200 consecutive patients (101 male; 72+/-9 years) attending our anti-coagulation clinic for the initiation of anticoagulation treatment with acenocoumarol. AF patients had a median CHADS2 score of 2 (1-2) and a median Framingham point-based risk score of 14 (9-21). Results of research indices in our AF patients were as follows: vWf 142.8+/-41.8 IU/dL and sE-sel 44 (31-62) ng/mL. There were significant correlations between plasma vWf levels and both risk CHADS2 and Framingham risk scores (vWf-CHADS2 risk score: Spearman, r=0.249, p<0.001; vWf-Framingham risk score: r=0.294, p<0.001). sE-sel did not show any significant correlation with both risk scores (sE-sel-CHADS2 risk score: r=-0.054, p=0.460; sE-sel-Framingham risk score: r=0.062, p=0.460). There were no statistically significant correlations between vWf and sE-sel (r=-0.127, p=0.081). Both CHADS2 and Framingham risk scores were significantly correlated with each other, r=0.627, p<0.001. In conclusion, in a wide cohort of non-selected and consecutive AF patients, endothelial damage/dysfunction (assessed by plasma vWf levels) but not endothelial activation (sE-sel) correlated with two new risk stratification scores for stroke in AF. Further prospective studies are needed to assess the prognostic role of prothrombotic indices in AF in relation to stroke and thromboembolic events, and their role in complementing clinical risk stratification schemas.
Similar articles
-
Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.Thromb Res. 2008;122(1):85-90. doi: 10.1016/j.thromres.2007.09.008. Epub 2007 Nov 8. Thromb Res. 2008. PMID: 17996280
-
Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.Eur J Clin Invest. 2013 Oct;43(10):1032-8. doi: 10.1111/eci.12140. Epub 2013 Aug 20. Eur J Clin Invest. 2013. PMID: 23961715
-
Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.J Intern Med. 2007 Jan;261(1):82-90. doi: 10.1111/j.1365-2796.2006.01735.x. J Intern Med. 2007. PMID: 17222171
-
Role of von Willebrand factor in vascular disease.Hamostaseologie. 2009 Jan;29(1):32-8. Hamostaseologie. 2009. PMID: 19151843 Review.
-
Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.Geriatrics. 2007 Mar;62(3):22-7. Geriatrics. 2007. PMID: 17346095 Review.
Cited by
-
Vascular effects of ultrafine particles in persons with type 2 diabetes.Environ Health Perspect. 2010 Dec;118(12):1692-8. doi: 10.1289/ehp.1002237. Epub 2010 Sep 7. Environ Health Perspect. 2010. PMID: 20822968 Free PMC article. Clinical Trial.
-
Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study.PLoS One. 2014 Jun 17;9(6):e99851. doi: 10.1371/journal.pone.0099851. eCollection 2014. PLoS One. 2014. PMID: 24937073 Free PMC article.
-
Von Willebrand Factor: Multimeric Structure and Functional Activity in Patients With Atrial Fibrillation With and Without Oral Anticoagulation.Clin Appl Thromb Hemost. 2018 May;24(4):647-654. doi: 10.1177/1076029617711803. Epub 2017 Jun 15. Clin Appl Thromb Hemost. 2018. PMID: 28618874 Free PMC article.
-
Prothrombotic risk factors and antithrombotic therapy in children with ischemic stroke.Ther Adv Neurol Disord. 2015 Mar;8(2):71-81. doi: 10.1177/1756285615573690. Ther Adv Neurol Disord. 2015. PMID: 25922619 Free PMC article.
-
Effect of Ginkgo leaf extract on vascular endothelial function in patients with early stage diabetic nephropathy.Chin J Integr Med. 2009 Feb;15(1):26-9. doi: 10.1007/s11655-009-0026-8. Epub 2009 Mar 7. Chin J Integr Med. 2009. PMID: 19271166 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous